adamantane has been researched along with Kahler Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badillo Patzmay, GV; Kwiecień, A; Lupidi, G; Nabissi, M; Pettinari, C; Pettinari, R; Santoni, G; Smoleński, P; Wołoszyn, A | 1 |
| An, N; Cai, H; Coker, W; Costa, LJ; Garrett-Mayer, E; Gibbs, K; Kang, Y; Matson, T; Ogretmen, B; Smith, C; Song, JH; Stuart, R; Venkata, JK; Wan, Z | 1 |
| Anderson, KC; Cartron, MA; Chauhan, D; Grabher, C; Hideshima, T; Lababidi, S; Podar, K; Raab, MS; Sattler, M; Tai, YT; Tonon, G; Vallet, S; Zhang, J; Zhou, Y; Zimmerhackl, A | 1 |
| Anderson, KC; Barilà, D; Chauhan, D; DePinho, RA; Hideshima, T; Podar, K; Raab, MS; Raje, N; Sattler, M; Tai, YT; Tonon, G; Yasui, H; Zhang, J | 1 |
1 trial(s) available for adamantane and Kahler Disease
| Article | Year |
|---|---|
Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.
Topics: Adamantane; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Enzyme Inhibitors; Humans; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Multiple Myeloma; Myeloid Cell Leukemia Sequence 1 Protein; Phosphotransferases (Alcohol Group Acceptor); Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Pyridines; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2014 |
3 other study(ies) available for adamantane and Kahler Disease
| Article | Year |
|---|---|
Ru(ii)-(PTA) and -mPTA complexes with N
Topics: 2,2'-Dipyridyl; Adamantane; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Humans; Multiple Myeloma; Nitrogen; Organophosphorus Compounds; Phenanthrolines; Ruthenium | 2017 |
Targeting angiogenesis via a c-Myc/hypoxia-inducible factor-1alpha-dependent pathway in multiple myeloma.
Topics: Adamantane; Angiogenesis Inhibitors; Animals; Blotting, Western; Cell Line, Tumor; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Humans; Hydroquinones; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Mice; Mice, Nude; Multiple Myeloma; Neovascularization, Pathologic; Proto-Oncogene Proteins c-myc; Vascular Endothelial Growth Factor A | 2009 |
Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myeloma.
Topics: Adamantane; Apoptosis; Benzamides; Boronic Acids; Bortezomib; Caspase Inhibitors; Caspases; Cell Growth Processes; Dexamethasone; Humans; Hydroquinones; Imatinib Mesylate; Leukemia, Erythroblastic, Acute; Melphalan; Multiple Myeloma; Piperazines; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-jun; Pyrazines; Pyrimidines; Transfection; Up-Regulation | 2007 |